These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31047270)

  • 21. Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.
    Ji S; Wei Y; Chen J; Tang S
    Int J Clin Pharm; 2017 Jun; 39(3):514-521. PubMed ID: 28386700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral Vascular Endothelial Dysfunction in Central Serous Chorioretinopathy.
    Wang NK; Fu Y; Wang JP; Kang EY; Wu AL; Tseng YJ; Yeh LK; Chen KJ; Wu WC; Ho WJ; Lai CC
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4524-4529. PubMed ID: 28877318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy.
    Framme C; Walter A; Berger L; Prahs P; Alt C; Theisen-Kunde D; Kowal J; Brinkmann R
    Ophthalmologica; 2015; 234(4):177-88. PubMed ID: 26368551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. En face choroidal vascular feature imaging in acute and chronic central serous chorioretinopathy using swept source optical coherence tomography.
    Lee WJ; Lee JW; Park SH; Lee BR
    Br J Ophthalmol; 2017 May; 101(5):580-586. PubMed ID: 27485721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitreoretinal interface in central serous choroidopathy: a retrospective case-control study.
    Theocharis IP; Lima LH
    Acta Ophthalmol; 2012 Nov; 90(7):e505-11. PubMed ID: 22863356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
    Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy.
    Framme C; Walter A; Gabler B; Roider J; Sachs HG; Gabel VP
    Acta Ophthalmol Scand; 2005 Apr; 83(2):161-7. PubMed ID: 15799726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
    Hamzah F; Shinojima A; Mori R; Yuzawa M
    BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy.
    Baek J; Park YH
    Am J Ophthalmol; 2015 Feb; 159(2):386-92. PubMed ID: 25447112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY.
    Agrawal R; Chhablani J; Tan KA; Shah S; Sarvaiya C; Banker A
    Retina; 2016 Sep; 36(9):1646-51. PubMed ID: 27124882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical quality in central serous chorioretinopathy.
    Lee K; Sohn J; Choi JG; Chung SK
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8598-603. PubMed ID: 25468888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis.
    Giusti C
    Med Hypotheses; 2004; 63(3):524-7. PubMed ID: 15288381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography.
    Sonoda S; Sakamoto T; Kuroiwa N; Arimura N; Kawano H; Yoshihara N; Yamashita T; Uchino E; Kinoshita T; Mitamura Y
    PLoS One; 2016; 11(6):e0157190. PubMed ID: 27305042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Hashizume K; Mizota A; Yuzawa M
    Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of serum endothelin-1 level in the etiopathogenesis of central serous chorioretinopathy.
    Türkçüoğlu P; Kadayifçilar S; Eldem B
    Am J Ophthalmol; 2006 Aug; 142(2):349-51. PubMed ID: 16876532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum erythropoietin levels in patients with central serous chorioretinopathy.
    Turgut B; Ilhan N; Uyar FY; Celiker U; Demir T; Koca SS
    Eye Brain; 2010; 2():77-81. PubMed ID: 28539767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).
    Lai TY; Wong RL; Chan WM
    Trans Am Ophthalmol Soc; 2015; 113():T8. PubMed ID: 26755855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4659-65. PubMed ID: 23737472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.